NCT01707836View on ClinicalTrials.gov

Neurofibromatosis Type 1 Brain Tumor Genetic Risk

CompletedOBSERVATIONAL
Enrollment

176

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

May 8, 2017

Study Completion Date

May 8, 2017

Conditions
Neurofibromatosis Type 1Pediatric Brain Tumor
Trial Locations (1)

63130

Washington University, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01707836 - Neurofibromatosis Type 1 Brain Tumor Genetic Risk | Biotech Hunter | Biotech Hunter